Version classiqueVersion mobile
OpenEdition Books

Intellectual Property and Public Health in the Developing World

 | 
Monirul Azam

List of Tables

Texte intégral

2.1

Patent applications and granted patents in Bangladesh (1995–2012)

42

2.2

Mailbox applications (pharmaceutical and agrochemical products)

43

2.3

The DGDA controls the quality of medicines produced in Bangladesh

48

2.4

Changes required for TRIPS-compliant pharmaceutical regulation in Bangladesh

58

2.5

Allopathic pharmaceutical companies in Bangladesh

61

2.6

The top 10 pharmaceutical companies in Bangladesh (2014)

62

2.7

Multinational pharmaceutical companies operating in Bangladesh

63

2.8

Pharmaceutical exports from Bangladesh (1975–2006)

65

2.9

Survey results regarding whether Bangladesh has the capacity to produce new medicines

71

2.10

Survey results on whether TRIPS has influenced the rise in pharmaceutical prices

75

2.11

Top 10 drugs in terms of sales in Bangladesh

76

2.12

Changes in retail price of 10 important drugs

77

2.13

Causes of death in Bangladesh

78

2.14

Diseases prevalent in Bangladesh

79

3.1

Policy options used by Brazil, India and South Africa

144

Acheter

Volume papier

Chargement

Unavailable